Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 16:07 | 5/15/24 | NEO | Health | Biolab | Testing Laboratories | Olivo Alicia C | FL | O | GC | 2 | S.d | -17 | 1.17 | 0 | -14 | 46 | D | |||||||||||||||
5/14/24 21:39 | 5/11/24 | NEO | Health | Biolab | Testing Laboratories | Smith Christopher M | FL | O | CEO | 1 | M.d | 0 | 0.00 | 0 | 96 | 16 | 679 | D | ||||||||||||||
5/14/24 21:38 | 5/11/24 | NEO | Health | Biolab | Testing Laboratories | Stone Warren | FL | O | Chief Co | 1 | M.d | 0 | 0.00 | 0 | 19 | 24 | 101 | D | ||||||||||||||
5/14/24 21:38 | 5/11/24 | NEO | Health | Biolab | Testing Laboratories | Sherman Jeffrey Scott | FL | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 26 | 21 | 149 | D | ||||||||||||||
5/14/24 21:38 | 5/11/24 | NEO | Health | Biolab | Testing Laboratories | Harris Melody | FL | O | Chf Ops | 1 | M.d | 0 | 0.00 | 0 | 7 | 7 | 108 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |